Finance

Beta
Lists
WAT:NYSE
Waters Corp
$369.18
0.00%
(0.00) 1D
Jun 24, 4:00:02 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for WAT...
Mkt. cap
36.25B
Avg. vol.
975.20K
Volume
12.00
P/E ratio
47.03
52-wk high
$414.15
52-wk low
$275.05
EPS
$7.85
Beta
1.21
Shares outstanding
98.19M
No. of employees
8K
Mkt. cap
36.25B
Avg. vol.
975.20K
Volume
12.00
P/E ratio
47.03
52-wk high
$414.15
52-wk low
$275.05
EPS
$7.85
Beta
1.21
Shares outstanding
98.19M
No. of employees
8K
News stories
From sources across the web
Profile
Waters Corporation is an American company headquartered in Milford, Massachusetts that provides analytical instruments and software used for chromatography, mass spectrometry, laboratory informatics, and rheometry by the life sciences, materials, and food industries. The company has primary manufacturing facilities in 9 U.S. locations as well as 11 international locations including Wexford, Wilmslow, Birmingham, Hüllhorst, Singapore, Bangalore, Beijing, and Shanghai. Major brands include ACQUITY UPC² / UPLC Systems and columns, Xevo mass spectrometry systems, Synapt MS / HDMS systems, Zodiac HPLC columns, XTerra HPLC columns, XBridge columns, Alliance HPLC systems, Empower chromatography software, MassLynx mass spectrometry software, Oasis sample preparation products, and NuGenesis lab management system. Its primary competitors are Agilent Technologies, Thermo Fisher Scientific, Revvity, and Danaher. Wikipedia
About Waters Corp
CEOUdit Batra
Employees7.9K
Founded1958
HeadquartersMilford, Massachusetts, United States
SectorHealth care
Websitewaters.com
Analyst Ratings
Based on 18 analysts giving stock ratings to WAT in the past 3 months
Buy
Buy
9
Hold
9
Sell
0
12 month forecast
Based on 18 Wall Street analysts offering 12 month price targets for WAT in the last 3 months.
Highest
Current $369.18
$440.00 (+19.18%)
Average
$389.53 (+5.51%)
Lowest
$345.00 (-6.55%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Luke Sergott
Barclays
Buy
Maintained
$425.00
+15.1%
06/24/2026
David Westenberg
Piper Sandler
Hold
Initiated
$400.00
+8.3%
06/11/2026
Sidharth Sahoo
HSBC
Buy
Maintained
$435.00
+17.8%
06/03/2026
Michael Ryskin
Bank of America Securities
Hold
Reiterated
$400.00
+8.3%
06/02/2026
Michael Polark
Wolfe Research
Buy
Maintained
$425.00
+15.1%
06/01/2026
Daniel Arias
Stifel Nicolaus
Hold
Maintained
$380.00
+2.9%
05/18/2026
Brandon Couillard
Wells Fargo
Hold
Maintained
$370.00
+0.2%
05/14/2026
Subbu Nambi
Guggenheim
Buy
Reiterated
$440.00
+19.2%
05/11/2026
Justin Bowers
Deutsche Bank
Hold
Maintained
$350.00
-5.2%
05/07/2026
Catherine Ramsey Schulte
Robert W. Baird
Buy
Maintained
$387.00
+4.8%
05/06/2026
Casey Woodring
J.P. Morgan
Hold
Reiterated
$345.00
-6.5%
05/06/2026
Lu Li
UBS
Hold
Maintained
$375.00
+1.6%
05/06/2026
Evie Koslosky
Goldman Sachs
Buy
Reiterated
$380.00
+2.9%
05/06/2026
Daniel Brennan
TD Cowen
Hold
Reiterated
$385.00
+4.3%
05/06/2026
Kallum Titchmarsh
Morgan Stanley
Hold
Maintained
$350.00
-5.2%
05/05/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
$350.00
-5.2%
05/05/2026
Matt Larew
William Blair
Buy
Maintained
-
-
05/05/2026
Patrick B Donnelly
Citi
Buy
Reiterated
$425.00
+15.1%
04/07/2026
Tycho Peterson
Jefferies
Buy
Reiterated
$470.00
+27.3%
02/10/2026
Last report
May 5, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$2.70 / $2.31
+16.99%beat
Revenue / Est. (USD)
1.27B / 1.20B
+5.30%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Apr 2026
Revenue
771.33M
799.89M
932.36M
1.27B
Cost of goods sold
321.41M
327.81M
362.86M
679.00M
Cost of revenue
321.41M
327.81M
362.86M
679.00M
Research and development expenses
48.55M
53.64M
46.90M
95.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
187.26M
187.23M
195.78M
305.00M
Operating expense
247.71M
252.97M
254.76M
552.00M
Total operating expenses
569.12M
580.77M
617.62M
1.23B
Operating income
202.21M
219.11M
314.74M
36.00M
Other non operating income
-676.00K
-69.00K
2.06M
1.00M
EBT including unusual items
177.69M
170.12M
264.18M
-88.00M
EBT excluding unusual items
191.69M
197.12M
308.18M
-5.00M
Income tax expense
30.58M
21.20M
38.97M
-16.00M
Effective tax rate
17.21%
12.46%
14.75%
18.18%
Other operating expenses
-
-
-
-
Net income
147.11M
148.92M
225.21M
-72.00M
Net profit margin
19.07%
18.62%
24.16%
-5.68%
Earnings per share
2.95
3.40
4.53
2.70
Interest and investment income
4.51M
4.71M
5.67M
6.00M
Interest expense
-14.35M
-26.64M
-14.29M
-48.00M
Net interest expenses
-9.85M
-21.92M
-8.62M
-42.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
253.86M
271.79M
367.28M
243.00M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer